More recently, the levels of transforming growth factor β 1 (TGF-β1) in the serum of patients with CCA were reported elevated, when compared with healthy controls, although the diagnostic capacity was not remarkable (AUC of 0.668). Here, TGFB1 is linked to cholangiocarcinoma.